showed more interest in it with the creation of a section for this medicine in the Health Ministry and then the setting up of a Chinese company to produce pharmaceuticals ( 中國藥材公司 -Zhongguo yaocai gongsi ) in March 1955. The first four universities of Chinese medicine opened in 1956 -at Beijing, Chengdu, Shanghai, and Guangzhou. The idea took shape around then of "unifying Chinese medicine and Western medicine" ( 中西 醫結合 -Zhongxiyi jiehe ), and then in 1958 came the famous slogan "Chinese medicine and pharmacology are a great treasure" ( 中國醫藥學是一個 偉大的寶庫 -Zhongguo yiyaoxue shi yi ge weida de baoku ). With this rose the notion of national "treasure."
In order to show the "scientificity" of Chinese medicine or at least its rational character, work was done on the process stretching from diagnostics to treatment. The concept of "bianzheng lunzhi" ( 辯證論治 ), (4) which may be rendered as "syndrome differentiation and discussion of treatments," was forged from 1950. Even though it can be easily shown that there is a continuity between this way of medical reasoning and the pre-1950 texts, the fact remains that the willingness to build from that time on a group of doctrines where the determination -amid the forest of clinical symptoms -of what constituted the real nature of the disease systematically accorded with the treatment adopted, seemed to be a new stage in the establishment henceforth of Chinese medicine as a competitor to "Western medicine."
From an administrative perspective, several decisions sealed the authorities' firm backing for Chinese medicine. For instance, it was included in Article 21 of the 1982 Constitution pertaining to health. In 1988 the National Bureau of Chinese Medicine and Pharmacology ( 中醫藥管理局 -Zhongyiyao guanli ju ) was established. In the 10 th Five Year Plan (2000) (2001) (2002) (2003) (2004) (2005) , it was decided to boost Chinese medicine's profile in health institutions. (5) Notwithstanding this intention, there was a qualitative and quantitative deterioration. China Daily reported on 29 April 2009 that the number of doctors practising Western medicine stood at about 5.5 million, whereas there were just 400,000 TCM practitioners, or 20 percent fewer than 50 years earlier.
It was in this context that some elements of Chinese medicine practices were included in the national list of intangible heritage, before the acceptance of acupuncture and moxibustion on UNESCO's representative list. Alongside these developments, however, Chinese medicine's actual status in the country has remained fragile. It is threatened by internal factors to do with standardisation and the break in transmission of knowledge, as well as by external ones that question its legitimacy.
Standardisation of teaching
Standardisation has affected many domains. The gradual changes adopted in university teaching since 1956 have led to the replacement of the master-disciple model with selectivity in the materials handed down and an abandonment of the reading and study of medical classics in favour of manuals produced for the new regimen. (6) Students' intellectual achievements do not make for familiarity with ancient texts; in 1999, for instance, the common material for all university graduates was philosophy, contemporary Chinese, and English, but not classical Chinese. In 2008, it was estimated that among all courses for Chinese medicine students, the actual hours devoted to the discipline proper constituted just half of the total, the rest taken up by Western medicine courses and those common for all graduates. (7)
Standardisation and industrialisation
In Chinese medicine, prescriptions ( 方 -fang ) must be adapted to the patient's idiosyncrasies. Using a basic formulation, the doctor juggles with dosages but also removes or adds one (most often) or many drugs in the composition, trying to best meet the individual characteristics of the pathological situation being dealt with. Such subtlety in the art of prescription becomes very difficult to apply when the doctor no longer has recourse to medicines prepared on the spot by the pharmacy or by the patient concerned, but has to rely on pharmaceutical industry products, which can only be of the standardised kind. This is what is known as manufactured drugs ( 中成藥 -zhongchengyao ) ready for consumption, which have since 1992 benefited from protective measures favouring industrialisation so long as they respond to various effectiveness criteria. (8) One of the specificities demanded of Chinese medicine, namely individualisation of treatments, is thus called into question by the perhaps unavoidable transformation of the marketing of traditional medicines.
Since the 1990s and in the context of China's accession to the World Trade Organisation (WTO), it became imperative to conform to international standards (Good Agricultural Practices, GAP) in farm production conditions, including of plants forming raw material for pharmaceuticals. (9) This led to the formulation of a document known as "Good Agricultural Practices for Chinese Crude Drugs" promulgated in 2003 by the Guojia shipin yaopin jiandu guanli ju ( 國家食品藥品監督管理局 -State Food and Drug Administration ), containing 104 criteria for evaluation. They cover everything from farming environment, cultivation methods, and hygiene conditions to the qualification of personnel. Its application can only lead to the exclusion of small producers and, consequently, of the loss of traditional know-how. In 2004, in fact, 80 percent of the medicinal plants on the market came from private farmers lacking a vendor status. Moreover, the high financial cost of obtaining certification can only benefit big industrial producers. (10) However well founded the quality expectations in farm production, this policy will reduce the diversity of plants used in Chinese medicine.
A similar phenomenon can be observed with regard to simple drugs ( 飲 片 -yinpian ), (11) 11. The word "drug" is used in the sense of "natural ingredient for preparing medicines."
12. Chinese medicine in general uses several ingredients (often between five and ten) for a prescription, each ingredient having a specific role in the formulation.
traditional medicine field and have become indispensable for market access since 2008. (13) At the start of that year, a mere 200 of the 1,100 registered companies making drugs had obtained GMP certification. It is likely that many firms will disappear, lacking the economic means to obtain this certification.
The issue of knowledge transmission
The knowledge transmission model for Chinese medicine through universities has shown limitations, and attempts have been underway since the 1990s to reappraise the master-discipline ( 師徒傳承 -Shitu chuancheng ) teaching model. This is echoed in the major transmission system (living human treasure, discussed infra) for national elements of intangible cultural heritage. In 1990, as many as 462 "famous and veteran" practicians and 725 disciples were chosen, (14) and in this way 2,200 students were trained between 1990 and 2005. However, it should be noted that many of these students had already been doctors.
In 1999, this situation was formalised with the Ministry of Health's decree introducing a master-apprentice transmission contract ( 師承關係合同 -shicheng guanxi hetong ). An equivalent rating with university teaching became possible, following tests of knowledge. The teacher must be a doctor with more than 15 years of clinical practice. A standard contract was proposed in 2006. An evaluation is made at the end of three years, and successful candidates receive a certificate of aptitude in traditional medicine through the master-apprentice method. But it does not amount to the title of physician. (15) 
External criticism
While the internal organisation of the practice and teaching of Chinese medicine might threaten its cohesion, external criticism can also destabilise it. A section of China's scientific community seems to have little time for it. In a shocking episode in 2006, Zhang Gongyao ( 張功耀 ), a professor at Zhongnan University ( 中南 ) at Changsha ( 長沙 ) in Hunan published an article calling for the abolition of Chinese medicine and pharmacology. (16) His argument, going over ground already covered in some instances by modernist opponents of Chinese medicine at the start of the Republican era, made four points: much of Chinese medicine must be ranged alongside the quaint and the magical, its ways are less rational than that of biomedicine, it uses products drawn from endangered species, and many drugs are toxic. And the Xinhua News Agency put out an incisive article on 12 September 2006 pointing to the dangers of Chinese medicine, especially the toxicity of "natural remedies." Of course, the "opposing camp" reacted quickly (Xinhua, 19 October 2006) ; nevertheless, some of these criticisms did influence the course of Chinese medicine.
The toxicity of some traditional medicines, which has been taken into account throughout the long history of Chinese medicines, (17) has led to several debates over the past two decades, in China and elsewhere. In 1993, Belgian doctors identified a kind of vine, Aristolochia fangchi ( 廣仿己 -guangfangji ), or more specifically, aristolochic acid -nephrotoxic and carcinogenic molecule -contained in this plant, as the source of serious nephropathy cases. This drug was part of the composition of a formula used in dieting regimes. (18) In March 2003, a damages claim was lodged in a Chinese court against the Tongren Tang group (19) by a patient suffering from uraemia, blamed on the consumption of the company's product "Gentian pill to drain the liver" ( 龍膽瀉肝丸 -longdan xiegan wan ). (20) The claim was rejected, as the consumer had to provide proof establishing the causality link. For a year, more such claims were lodged and met with similar dismissals. Be that as it may, this episode signalled a new awareness among Chinese consumers. As in the West, pharmaceutical products in general are regarded with mixed feelings of suspicion and expectation of effectiveness without side effects. Aristolochia manshuriensis was banned in April 2003 by the Guojia shipin yaopin jiandu guanli ju, while six other medicinal plants of the Aristolochia family were also banned in August 2004. (21) This trend had consequences for research into Chinese medicine, which mainly tends to prove the innocuousness and effectiveness of traditional drugs. The 1998 administrative regulation of the National Bureau of Chinese Medicine and Pharmacology specified that research on Chinese medicine must be open to evaluation and verification following modern, precise scientific criteria. Most research projects in this domain focus on molecular pharmacology and the characterisation and extraction of active ingredients. For instance, in 2005, the Guojia ziran kexue jijin ( 國家自然科學基金 -National Natural Science Foundation of China ), which provides the most funds to the Chinese Academy of Medical Sciences, (22) backed 173 projects relating to Chinese medicine and pharmacology. Of these, 75 percent involved clinical observation of the treatment of a disease using a given pharmaceutical formula and the identification of active ingredients. In a way, such research could be carried out on any "traditional" medicine anywhere on earth, since the internal theoretical coherence of the medical system envisaged is ignored. The link between a substance's toxicity and its therapeutic effectiveness was made in ancient China itself, and the preparation of drugs has often sought to overcome potential dangers. But testing the effect of prescriptions, which combine several products, is much more difficult in view of possible interactions. (25) UNESCO offers the following definition, in which the importance attached to the notion of "communities" as custodians is worth noting:
The 'Intangible Cultural Heritage' means the practices, representations, expressions, knowledge, skills -as well as the instruments, objects, artefacts and cultural spaces associated therewith -that communities, groups and, in some cases, individuals recognize as part of their cultural heritage. This intangible cultural heritage, transmitted from generation to generation, is constantly recreated by communities and groups in response to their environment, their interaction with nature and their history, and provides them with a sense of identity and continuity, thus promoting respect for cultural diversity and human creativity.
The gradual development of the ICH concept can be traced back to the 1950s, when "folklore" was deemed to be in the public domain, not enjoying copyright protection. In 1973, Bolivia asked UNESCO to consider protecting folklore, the idea being that it could be in the state's domain. The 1982 World Conference on Cultural Policies in Mexico City agreed to treat cultural traditions the same as monuments. In 1989, the "Recommendation on the Safeguarding of Traditional Culture and Folklore" was adopted. Its main aim to promote studies on folklore and enhance skills, but the intellectual property aspect was ignored despite previous discussions with the World Intellectual Property Organisation (WIPO).
Attention then turned to the notion of intangible cultural heritage, in recognition of cultural practices and expressions not necessarily attached to a material form, object, frame, and so forth. It must be stressed that the 2003 Convention included so-called "elite" culture. ICH is thus not only "popular traditional culture." This must be borne in mind with regard to Chinese medicine, the fruit of scholarly work based on medical practices inherited from elites of yore.
Debates preceding the Convention's adoption were inspired by the desire to preserve what was initially called traditional and popular culture, which until the late 1980s meant research into "folklore." The growing feeling that globalisation was a threat to cultural diversity drew on previous experiences with the UNESCO lists of natural sites and monuments to forge the concept of "intangible cultural heritage."
The large number of activities that may be considered under ICH (oral traditions, performing art, social practices, rituals and festivals, the know-how needed for traditional crafts... ), (26) also included "knowledge and practices concerning nature and the universe":
This domain includes numerous areas such as traditional ecological wisdom, indigenous knowledge, knowledge about local fauna and flora, traditional healing systems, rituals, beliefs, initiatory rites, cosmologies, shamanism, possession rites, social organisations, festivals, languages and visual arts. -List of intangible heritage requiring urgent protection includes elements that communities concerned and states parties consider as necessitating urgent measures in order to ensure their transmission. Inclusion on this list helps mobilise international cooperation and assistance allowing stakeholders to take adequate protective measures. In 2009, the committee had included 12 elements, adding four more in 2010.
-Programmes, projects, and activities for safeguarding intangible cultural heritage. (28) The 2003 Convention also led to the "living human treasures" programme. These are "persons who possess to a high degree the knowledge and skills required for performing or recreating specific elements of the intangible cultural heritage." The programme was meant to encourage member states to accord official recognition to those carrying on a tradition and talented practitioners, as well as to ensure transmission of their know-how to younger generations. The "living human treasures" must be compared with the Chinese "representative transmitter" ( 傳承人 -chuancheng ren ) discussed earlier.
China and ICH
The notion of "heritage" does not have the same history in the West and China. It may be said that Western thought favoured material and monumental aspects of heritage. In Chinese thinking, the authentic search should go beyond the material and seek out know-how and ability. (33) Among the elements included in China's list of intangible cultural heritage, many pertain to Chinese medicine. They will be examined in greater detail.
Chinese medicine in the national lists of ICH The 2006 list
The first national heritage list in 2006 ( 國家名錄 -Guojia minglu ) contained nine elements from the medical domain. The nominations presented are accessible, with Chinese and English versions. (34) In general, the Chinese nominations are detailed and expanded, mentioning the title of the medical works, but these are ignored in the English version, which is clearly meant for an international public deemed almost totally ignorant of China's history and its medicinal systems. We will consider nine of these elements:
TCM approach to life and to disease
In Chinese it is Zhongyi shengming yu jibing renzhi fangfa ( 中醫生命与疾 病認知方法 ) and in English "The perception method of life and disease of TCM." The stakeholder is the Chinese Academy of Medical Sciences.
Recalling that Traditional Chinese Medicine ( TCM in English while in Chinese the text merely says zhongyi ) has a more than 2,000 years' history, the text sets out in highly simplified terms the conception of disease, noting basic elements of what may be called Chinese "correlative thinking": the Yin-Yang imbalance that lies behind health problems. The causative role of wuxing 五行 ("five agents," wood, fire, earth, metal, and water) are set out:
TCM uses a system of inter-relationships between the five elements to understand how the various processes of the body support and control each other. Because of these inter-relationships, when one of the organs and its associated element is out of balance, the other elements are also affected.
The text then quickly goes over the " wuyun liuqi 五運六氣 ," a system that was highly influential during the Song dynasty. (35) The theory of directing one's strength focuses on how various components such as astronomy, meteorological phenomena, and climate would affect health. This theory consists of two parts, five strengths, and six climatic factors.
Then the zang (spleen, heart, lungs, liver, and kidneys) and fu 腑 (small intestine, large intestine, gall bladder, bladder, stomach, and san jiao 三角 -"Triple Burner", an invisible metabolising organ in TCM concept) are cited, with the following explanation:
Each organ is considered to have its own functions, but these functions have a far wider scope than the purely physiological function described in Western medicine.
While this assertion is not in the nature of evidence, it is one of the topoi regularly used to explain the different ways of seeing the role of organs in Chinese and Western medicine. As enunciated here, it would suffice to say that they cannot be understood because they are insufficiently developed. Another explanation is given for the triple burner, an organ whose definition has been debated throughout Chinese history: "A three-part invisible metabolising organ in TCM concept." Clearly, this refers to a "formless" ( 無 形 -wuxing ) organ, (36) one of two conceptions (the other being that sanjiao "has form") of this organ. Attention must be paid in this definition to the term "metabolising," the scientific connotation of which lends modernist garb to Chinese medical thinking. The use of the word "metabolism" began as recently as the 1860s (37) with the development of biochemistry. At any rate, the term's use is not insignificant.
After a brief introduction to the role of "meridians," the text ends by hinting at Chinese medicine's precarious position:
But because of the influence of Western medicine, there are fewer people who understand and can pass on this knowledge system. Therefore, it is in great need of protection and development.
This clearly puts Chinese medicine in a position requiring protective measures in view of the growing dominance of Western medicine.
Chinese medicine's diagnostic methods.
The Chinese title is Zhongyi zhenfa ( 中醫診法 ) and in English "Diagnostic Methods of Chinese Medicine." The stakeholder is again the Chinese Academy of Medical Sciences.
A quick look at the Chinese medicinal system's four major diagnostic methods ( 四診 -sizhen ) follows: observation ( 望 -wang ), auscultation and olfaction ( 聞 -wen ), interrogation ( 問 -wen ), and pulse-taking and palpation ( 切 -qie ). The main difference between the Chinese and English versions is that the Chinese one mentions the major texts dealing with the subject, such as Maijing ( 脈經 -Pulse Classic ) by Wang Shuhe ( 王叔和 ) from the third century AD (late Han dynasty). The mention of such works in the Chinese version lends a historic depth lacking in the English one.
Techniques of preparing Chinese medical material
In Chinese it is Zhongyao paozhi jishu ( 中藥炮製技術 ), and in English "Technology of processing Chinese materia medica." The stakeholders are the Chinese Academy of Medical Sciences and the China Association of Traditional Chinese Medicine ( 中國中藥協會 -Zhongguo zhongyao xiehui ).
The element is quickly presented:
Processing Chinese materia medica means using traditional methods and technology to create herbal medicine slices. After processing, the medical effects of the medication are improved and the side effects decrease. Processing is a necessary procedure.
Then follows a succinct narration of the history of drug preparation techniques. The English version merely cites Shennong bencao jing ( 神農本草經 -The Divine Farmer's Herb-Root Classic ), from about the first century AD, and the Bencao gangmu ( 本草綱目 -Compendium of Materia Medica ) by Li Shizhen ( 李時珍 1596 ), while the Chinese one mentions the great classic Leigong paozhi lun ( 雷公砲灸論 -Leigong's Treatise on Drug Preparation ), a series of texts dating from the fifth century to the Song dynasty. It ends with a mention of the highly worrying situation as regards drug preparation know-how:
At present, there are only about 100 people working on processing materia medica, and the technology is in danger of dying out. Furthermore, some departments haven't paid enough attention to traditional processing technology or taken protective measures. Therefore, the technology of processing Chinese materia medica is in great need of protection.
Under these conditions, it seemed imperative to submit the nominations to UNESCO as elements to be included on the ICH list needing urgent protection.
Traditional galenic preparation methods in Chinese medicine
The Chinese title is Zhongyi chuantong zhiji fangfa ( 中醫傳統製劑方法 ), and in English, "The traditional preparation method of Chinese medicine." The stakeholders are the Chinese Academy of Medical Sciences and the China Association of Traditional Chinese Medicine.
Most succinctly, the text presents the main galenic forms used in Chinese medicine: pills ( 丸 -wan and 丹 -dan ), powders ( 散 -san ), pomades ( 膏 -gao ), and decoctions ( 湯 -tang ). It is worth noting the hoary antiquity (Shang dynasty or earlier) of some modes of drug preparation, especially of 藥酒 -yaojiu , rendered in English as "medicated alcohol," the "alcohol" there being rather anachronistic.
Acupuncture and moxibustion.
Zhenjiu ( 針灸 ) in Chinese is rendered in English as "acupuncture." The stakeholders are the Chinese Academy of Medical Sciences and the China Association of Acupuncture and Moxibustion ( 中國針灸學會 -Zhongguo zhenjiuxue hui ).
The English text begins with an assertion in an apparent quest for legitimation in the eyes of international observers:
Acupuncture is an important part of Chinese medicine. It was initially invented as a technique of medical treatment and gradually became a science.
Following a brief introduction, the text contains a part on acupuncture's history and another on Zhenjiu jiayi jing ( 針灸甲乙經 ) by Huangfu Mi (with a vulgar error in the English text, "Huang Fumi") 皇甫謐 (214-282) . The text later led to a more detailed version that helped include acupuncture in UNESCO's list in 2010.
Techniques for healing fractures in Chinese medicine
Zhongyi zhenggu liaofa ( 中醫正骨療法 ) is given as "Chinese medicine bonesetting techniques" in English. The stakeholder is the Chinese Academy of Medical Sciences.
The short (eight-line) English text notes that accounts existed in antiquity relating to healing bone fractures and use of splints. The use of small splints ( 小夾板 -xiaojiaban ) is presented as China's contribution to global medicine. The text stresses that such methods are disappearing for economic reasons; the slightly longer Chinese text specifies that such techniques are only to be found in ten or so Chinese medicine hospitals.
Medicinal culture of the Tongren tang Chinese pharmacy
Tongren tang zhongyiyao wenhua ( 同仁堂中醫藥文化 ): In English, "Culture of the Tong Ren Tang Drugstore." The stakeholder is the Tongren Tang company.
The text briefly introduces the famous pharmacy and its products. Tongren Tang's history is noteworthy. Founded in Beijing by Yue Xianyang ( 樂 顯揚 ) in 1669, the pharmacy gradually emerged as a veritable industrial enterprise and is one of the most prestigious instances of pharmacy's importance in Chinese medicine. It also illustrates the success of a commercial development strategy that was able to draw on close connections to the central authorities.
It was Yue Fengming ( 樂風鳴 ), son of Yue Xianyang, who opened the first shop in 1702, near Qianmen ( 前門 ) at Dashalan ( 大柵欄 ), a commercial district known to be closest to the imperial court. Yue Fengming secured a medical official's post and in 1723 became the designated supplier of medicines to the court. Tongren Tang's history is in some ways the story of commercial success shrewdly pursued through imperial patronage. Fires ravaged the pharmacy in 1753 and 1834, but the firm prospered nevertheless: by the late Qing it sought to guard against rivals' machinations and by investing in charitable works. In the twentieth century, 34 other pharmacies with the Tongren Tang brand name opened between 1907 and 1949, all following the traditional model and not imitating the Western style. In this sense, Tongren Tang symbolises pharmaceuticals "à la chinoise." (38) 
Medicinal Culture Huqingyu tang Chinese pharmacy
Huqingyu tang zhongyao wenhua ( 胡慶余堂中藥文化 ): in English, "Culture of the Hu Qing Yu Tang Drugstore." The stakeholder is the Huqingyu Tang Chinese Medicine Museum.
Huqingyu ( silk and tea trade among other activities, Hu Xueyan also produced pharmaceuticals, which gave rise to the name Huqingyu (in which qingyu invokes yuqing 余慶 , the "joy inherited from virtuous parents"). The beautiful commercial building that housed the pharmacy was turned into a Chinese medicine and pharmacopeia museum in 1991. Both the English and Chinese texts note that Huqingyu pharmacy, or rather Hu Xueyan himself, had a commercial attitude based on jieqi ( 戒欺 -avoiding deception ). It would seem that the stress on such moral rectitude in business could have contemporary echoes.
Tibetan medicine
In Chinese it is Zang yiyao ( 藏醫藥 ) and in English "Tibetan medicine and pharmacopoeia." The stakeholders are: Lhasa's northern school of Tibetan medicine's mercury cleansing and refining techniques, and Tibetan pharmacopoeia and herbal preparation techniques of Renqen Changjor, Garzê prefecture's southern school of Tibetan medicine and pharmacopoeia.
The rather long text includes a general introduction beginning thus:
Tibetan medicine, one of the world's oldest ancient medical systems that began over 2300 years ago, is a mix of science, art, and philosophy that takes a holistic approach to health care.
Reading the rest of the text, it is difficult to make out Tibetan medicine's development. Tibetan medicine's basic work, Rgyud-bzhi ("Four Treatises"), is mentioned only in passing and in the last paragraph, after examining the North and South Schools. As is well known, Tibetan medicine is made up of the double influence of India's Ayurveda and Chinese medicine, something the text totally ignores. (41) The Chinese version is presented in a much different way and highlights techniques of mercury processing in Tibetan medicine. This is not the place to consider political issues regarding Tibet and China, but it seems rather improbable that Tibetan medicine would be submitted to UNESCO for inclusion as an ICH.
The 2008 and 2011 lists
The 2008 national heritage list has eight elements from the medical domain: (42) 1. Preparations for "life cultivation" in Chinese medicine ( 中醫養生 -Zhongyi yangsheng ). 2. Medicinal culture and traditional Chinese pharmacology ( 傳統中醫藥 文化 -chuantong zhongyiyao wenhua ): texts offered by pharmacies and pharmaceutical firms. 3. Mongolian medicine and pharmacology ( 蒙醫藥 -Meng yiyao ). 4. She nationality medicine and pharmacology ( 族醫藥 -Shezu yiyao ).
The She are a minority nationality in Zhejiang and Fujian. 5. Yao nationality medicine and pharmacology ( 瑤族醫藥 -Yaozu yiyao ).
The Yao are a minority nationality in Guizhou. 6. Miao nationality medicine and pharmacology ( 苗醫藥 -Miao yiyao ).
The Miao are a minority nationality (Hmong) in southern China's mountainous areas. 7. Dong medicine and pharmacology ( 侗醫藥 -Dong yiyao ). The Dong are a minority nationality in Yunnan. 8. Hui medicine and pharmacology ( 回族醫藥 -Huizu yiyao ). The Hui are a Muslim minority. (43) Finally, the third list in 2011 (44) included one item: Medicine and pharmacology of the Dai ( 傣醫藥 -Dai yiyao ), a minority nationality in Yunnan.
As is clear, these primarily concern minority nationalities' medicinal practices. • Wooden movable type printing; • Meshrep; (46) • The watertight-bulkhead technology of Chinese junks.
Inclusion of acupuncture and moxibustion in
The committee also decided to include two elements on the Representative List of the Intangible Cultural Heritage of Humanity :
• Acupuncture and moxibustion in Chinese traditional medicine; • Peking opera.
• On acupuncture and moxibustion in Traditional Chinese Medicine, the UNESCO site said: (47) Acupuncture and moxibustion are forms of traditional Chinese medicine widely practised in China and also found in regions of south-east Asia, Europe and the Americas. The theories of acupuncture and moxibustion hold that the human body acts as a small universe connected by channels, and that by physically stimulating these channels the practitioner can promote the human body's selfregulating functions and bring health to the patient. This stimulation involves the burning of moxa (mugwort) or the insertion of needles into points on these channels, with the aim to restore the body's balance and prevent and treat disease. In acupuncture, needles are selected according to the individual condition and used to puncture and stimulate the chosen points. Moxibustion is usually divided into direct and indirect moxibustion, in which either moxa cones are placed directly on points or moxa sticks are held and kept at some distance from the body surface to warm the chosen area. Moxa cones and sticks are made of dried mugwort leaves. Acupuncture and moxibustion are taught through verbal instruction and demonstration, transmitted through master-disciple relations or through members of a clan. Currently, acupuncture and moxibustion are also transmitted through formal academic education.
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